CHICAGO, Nov. 13, 2024 /PRNewswire/ -- Ocean Tomo Transactions, a part of J.S. Held, announces the sale of the world's ...
Phase 2 trial initiation in patients with sleep /wake disorders results in milestone payment of US$3.5 million to Nxera Tokyo, Japan and Cambridge, UK, 13 November 2024 – Nxera Pharma Co., Ltd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback